Patents by Inventor Alan Hewitt

Alan Hewitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931168
    Abstract: Systems and methods for speech-controlled or speech-enabled health monitoring of a subject are described. A device includes a substrate configured to support a subject, a plurality of non-contact sensors configured to capture acoustic signals and force signals with respect to the subject, an audio interface configured to communicate with the subject, and a processor in connection with the plurality of sensors and the audio interface. The processor configured to determine biosignals from one or more of the acoustic signals and the force signals to monitor a subject's health status, and detect presence of speech in the acoustic signals. The audio interface configured to interactively communicate with at least one of the subject or an entity associated with the subject based on at least one of an action needed due to the subject's health status and a verbal command in detected speech.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: March 19, 2024
    Assignee: Sleep Number Corporation
    Inventors: Omid Sayadi, Steven Jay Young, Carl Hewitt, Alan Luckow
  • Publication number: 20220152047
    Abstract: Provides herein are compositions for the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith, comprising an estrogen, optionally estriol, and a tricyclic antidepressant, optionally amitriptyline, formulated for topical, transdermal or transmucosal administration. Also provided are methods for the production of said compositions and to uses thereof in the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith.
    Type: Application
    Filed: February 3, 2022
    Publication date: May 19, 2022
    Applicant: TA Pharma Pty Limited
    Inventors: Thierry VANCAILLIE, Alan HEWITT
  • Patent number: 11273164
    Abstract: Provides herein are compositions for the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith, comprising an estrogen, optionally estriol, and a tricyclic antidepressant, optionally amitriptyline, formulated for topical, transdermal or transmucosal administration. Also provided are methods for the production of said compositions and to uses thereof in the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: March 15, 2022
    Assignee: TA Pharma Pty Limited
    Inventors: Thierry Vancaillie, Alan Hewitt
  • Publication number: 20190099432
    Abstract: Provides herein are compositions for the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith, comprising an estrogen, optionally estriol, and a tricyclic antidepressant, optionally amitriptyline, formulated for topical, transdermal or transmucosal administration. Also provided are methods for the production of said compositions and to uses thereof in the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith.
    Type: Application
    Filed: May 1, 2017
    Publication date: April 4, 2019
    Applicant: T & A Pharma Pty Limited
    Inventors: Thierry VANCAILLIE, Alan HEWITT
  • Patent number: 8828435
    Abstract: A buccal delivery system capable of being blended in a normal dry powder process and compressed using a standard tabletting machine, said buccal delivery system comprising a matrix of: (a) an effective amount of one or more active ingredients; (b) an amount of one or more polyethylene glycols or derivatives thereof having a molecular weight between 1000 to 8000 sufficient to provide the required hardness and time for dissolution of the matrix; (c) 0.05-2% by weight of the total matrix of one or more suspending agents; (d) 0.05-2% by weight of the total matrix of one or more flowing agents; and (e) 0.05-2% by weight of the total matrix of one or more sweeteners.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: September 9, 2014
    Assignee: Lingual Consegna Pty Ltd
    Inventors: Ernest Alan Hewitt, Richard James Stenlake
  • Publication number: 20120129819
    Abstract: The present invention provides a pharmaceutical composition in the form of a water-based gel comprising: at least one pharmaceutically active compound; at least one gelling agent; a solubilising agent; and water, wherein said composition is free or substantially free of unsubstituted monohydric alcohols having between 1 and 6 carbon atoms. The invention also relates to methods for preparing the compositions and uses thereof.
    Type: Application
    Filed: April 14, 2010
    Publication date: May 24, 2012
    Applicant: Medortus (UK) Ltd
    Inventors: Thierry Vancaillie, Alan Hewitt
  • Publication number: 20110123619
    Abstract: A buccal delivery system capable of being blended in a normal dry powder process and compressed using a standard tabletting machine, said buccal delivery system comprising a matrix of: (a) an effective amount of one or more active ingredients; (b) an amount of one or more polyethylene glycols or derivatives thereof having a molecular weight between 1000 to 8000 sufficient to provide the required hardness and time for dissolution of the matrix; (c) 0.05-2% by weight of the total matrix of one or more suspending agents; (d) 0.05-2% by weight of the total matrix of one or more flowing agents; and (e) 0.05-2% by weight of the total matrix of one or more sweeteners.
    Type: Application
    Filed: February 4, 2011
    Publication date: May 26, 2011
    Applicant: OZPHARMA PTY. LTD.
    Inventors: Ernest Alan Hewitt, Richard James Stenlake
  • Publication number: 20080317850
    Abstract: A buccal delivery system capable of being blended in a normal dry powder process and compressed using a standard tabletting machine, said buccal delivery system comprising a matrix of: (a) an effective amount of one or more active ingredients; (b) an amount of one or more polyethylene glycols or derivatives thereof having a molecular weight between 1000 to 8000 sufficient to provide the required hardness and time for dissolution of the matrix; (c) 0.05-2% by weight of the total matrix of one or more suspending agents; (d) 0.05-2% by weight of the total matrix of one or more flowing agents; and (e) 0.05-2% by weight of the total matrix of one or more sweeteners.
    Type: Application
    Filed: April 7, 2006
    Publication date: December 25, 2008
    Inventors: Ernest Alan Hewitt, Richard James Stenlake
  • Publication number: 20080242731
    Abstract: The present invention relates to topical anaesthetic compositions, uses thereof and methods for their preparation.
    Type: Application
    Filed: March 25, 2008
    Publication date: October 2, 2008
    Inventors: Thierry Vancaillie, Alan Hewitt
  • Publication number: 20050084508
    Abstract: For use in bodily cavities, a topical anesthetic combination having a pH adjusted to optimize the effectiveness of the anesthetic, a viscosity appropriate to displace tissue debris and enhance retention, and addition of chemicals which increase the bio-availability of the anesthetic molecules.
    Type: Application
    Filed: December 6, 2004
    Publication date: April 21, 2005
    Inventors: Thierry Vancaillie, Alan Hewitt
  • Patent number: 6453026
    Abstract: An architecture for communicating with telemetering interface units (TIUs). The system comprises an application controller which interfaces with service vendors who make requests for telemetering metering actions and/or control actions; or network server for communicating via UTTs, (Utility Telemetry Trunks), with an end office switch for accessing TIUs, using a suppressed ringing connection to distinguish between telemetering connections and telephone connections; a service control point (SCP), for providing data about the telecommunications network, the data being necessary in order to allow the network server to access the correct TIU, and a data network for interconnecting the application controller, network server and switching control point. Advantageously, using this arrangement, the functions of the application controller which interfaces with the service vendor are segregated from the functions for controlling the telecommunication network to access the TIU.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: September 17, 2002
    Assignee: Lucent Technologies Inc.
    Inventors: Stuart Mandel Garland, William Alan Hewitt
  • Patent number: 5754628
    Abstract: A method of operating a telecommunications network to provide network-based messaging services includes utilizing a communication link between the network and a telephone adjunct interface. The adjunct interface detects and alerts the subscriber to the existence of waiting messages. In accordance with an illustrative embodiment of the invention, a combination of AC ring detection and outcall polling of the network is employed to determine whether any messages have been received by the network service platform. Specifically, if the subscriber phone is not answered after a predetermined number of rings, the interface polls the network after a suitable delay to determine if any messages were left. If so, the network transmits a code or other signal that is recognized by the interface device, and a visual and/or audible indication is then provided to the subscriber.
    Type: Grant
    Filed: May 6, 1997
    Date of Patent: May 19, 1998
    Assignee: AT&T Corp
    Inventors: Burt Joseph Bossi, William Alan Hewitt, Stephen Dale Hoskins
  • Patent number: 5664008
    Abstract: A telephone adjunct interface for use with a network-based voice and/or data message storage and delivery service detects and alerts the subscriber to the existence of waiting messages. The interface device utilizes a combination of AC ring detection and outcall polling of the network to determine whether a visual and/or audible notification should be provided to the subscriber. That is, if the subscriber phone is not answered after a selected number of rings, the interface polls the network after a suitable delay to determine if any messages were left. If the subscriber line is busy or on call-forward while a calling party is seeking to leave a message, the network service platform stores the message and waits a selected interval before seeking to alert the subscriber. Advantageously, the device is configured as a small, portable and inexpensive consumer premise unit which connects easily to all standard analog telephone systems that use modular connectors.
    Type: Grant
    Filed: December 11, 1995
    Date of Patent: September 2, 1997
    Assignee: AT&T
    Inventors: Burt Joseph Bossi, William Alan Hewitt, Stephen Dale Hoskins